Tirzepatide (LY3298176) is one of the most thoroughly characterised incretin peptides in current metabolic research, having completed an extensive Phase 3 clinical trial programme spanning both obesity and type 2 diabetes populations. As a dual agonist of the GIP and GLP-1 receptors, it occupies a mechanistic position between single-receptor compounds like semaglutide and triple-receptor compounds like retatrutide. For a deeper scientific overview of the compound's mechanism, see our Tirzepatide research overview. For researchers in Malaysia studying metabolic pathways, insulin resistance, or obesity, Tirzepatide is now accessible locally through Concept Peptides without the complications of international ordering.

Note: Tirzepatide supplied by Concept Peptides is a research-grade compound intended strictly for laboratory and preclinical research purposes. It is not for human consumption. Researchers requiring tirzepatide for clinical or licensed medical use should approach their institutional pharmacy or a licensed pharmaceutical distributor.

What Makes Tirzepatide Different?

Dual Receptor Mechanism

Most first-generation GLP-1 based compounds work primarily through appetite suppression and delayed gastric emptying. Tirzepatide adds a second layer:

  • GIP receptor agonism: Historically associated with fat storage at physiological levels, but shown in tirzepatide's research programme to potentiate GLP-1-mediated satiety and reduce nausea when co-activated pharmacologically.
  • GLP-1 receptor agonism: Engineered with lower binding affinity than native GLP-1 or semaglutide, a design intended to broaden the therapeutic window by moderating gastrointestinal side effects while preserving efficacy.

Phase 3 Trial Results

Data published in the New England Journal of Medicine (2022) from Eli Lilly's SURMOUNT-1 trial showed subjects in the highest dose group (15mg weekly) achieving a mean 20.9% reduction in body weight at 72 weeks. Tirzepatide has since been studied in additional populations, including the SURPASS programme for type 2 diabetes and SURMOUNT-OSA for obstructive sleep apnoea, making it one of the most extensively documented incretin peptides in the current research literature.

Comparison to Related Compounds

Tirzepatide's dual-receptor mechanism sits between semaglutide (GLP-1 only) and retatrutide (GLP-1/GIP/glucagon triple agonist). For a detailed comparison of the trial data and mechanistic distinctions between tirzepatide and retatrutide, see our Tirzepatide vs Retatrutide article.

How to Buy Tirzepatide in Malaysia

Local vs Overseas Sourcing

Tirzepatide research peptide sourced from overseas typically arrives in 3–5 weeks and involves customs risk. As a Malaysia-based supplier, Concept Peptides ships Tirzepatide domestically with 1–3 business day delivery and no import complications. Every product is accompanied by a third-party Certificate of Analysis confirming sequence accuracy and purity.

What Format Is It Supplied In?

Concept Peptides supplies Tirzepatide as a lyophilised (freeze-dried) powder in sealed research vials, available in 10mg and 20mg sizes. Lyophilisation preserves stability and extends shelf life prior to reconstitution. It is reconstituted with BAC Water prior to use. A free BAC Water vial is included with every Tirzepatide order.

Purity Verification

Every product is independently tested by a third-party laboratory and a Certificate of Analysis (COA) is available upon request, confirming the amino acid sequence, molecular weight, and purity percentage by HPLC.

Buy Tirzepatide in Malaysia β€” third-party tested, local stock
Shop Tirzepatide

Frequently Asked Questions

What is Tirzepatide used for in research?

Tirzepatide is used in preclinical and research settings to study the GIP and GLP-1 receptor pathways β€” particularly their combined effects on energy balance, insulin secretion, glycaemic control, and body composition.

How does Tirzepatide compare to semaglutide and retatrutide?

Semaglutide is a GLP-1 receptor agonist only. Tirzepatide adds GIP receptor agonism on top of GLP-1R activity. Retatrutide goes a step further, adding glucagon receptor agonism for additional thermogenic and hepatic fat-clearing effects. For a broader look at GLP-1 class compounds available for Malaysian researchers, see our GLP-1 peptides Malaysia guide, and for a comparison of the leading weight-loss peptides, see our overview of the best peptides for weight loss Malaysia.

Is Tirzepatide available in Malaysia?

Yes β€” Concept Peptides stocks Tirzepatide in lyophilised research-grade format, available for order with local payment methods and domestic shipping throughout Malaysia.

How should Tirzepatide be stored after arrival?

Lyophilised Tirzepatide should be stored at -20Β°C for long-term stability. If the vial will be used within 4–6 weeks, storage at 2–8Β°C is acceptable. Once reconstituted with BAC water, store the solution at 2–8Β°C and use within 28 days. Avoid repeated freeze-thaw cycles of the reconstituted preparation.

References

  1. Jastreboff AM, Aronne LJ, Ahmad NN, et al. "Tirzepatide Once Weekly for the Treatment of Obesity." New England Journal of Medicine. 2022;387(3):205–216.